Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.
Appel
Heiner
H
Department of Gastroenterology, Infectiology and Rheumatology, Charité Berlin, Campus Benjamin Franklin, Berlin, Germany. heiner.appel@charite.de
Hermann
Kay-Geert A
KG
Althoff
Christian E
CE
Rudwaleit
Martin
M
Sieper
Joachim
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome; D051598:Whole Body Imaging
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab